US Stock MarketDetailed Quotes

NewAmsterdam Pharma (NAMS)

Watchlist
  • 37.750
  • -1.140-2.93%
Close May 13 16:00 ET
  • 37.750
  • 0.0000.00%
Post 16:10 ET
4.41BMarket Cap-21.21P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NewAmsterdam Pharma (NAMS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
2.08%3.04M
-50.61%22.5M
-99.75%32K
-98.80%348K
740.06%19.15M
112.56%2.98M
223.37%45.56M
1,490.54%12.77M
889.83%29.11M
32.73%2.28M
Operating revenue
2.08%3.04M
-50.61%22.5M
-99.75%32K
-98.80%348K
740.06%19.15M
112.56%2.98M
223.37%45.56M
1,490.54%12.77M
889.83%29.11M
32.73%2.28M
Cost of revenue
Gross profit
Operating expense
-14.52%61.46M
11.87%248.19M
17.88%66.01M
2.54%55.49M
-0.13%54.78M
26.41%71.9M
12.58%221.85M
-3.21%56M
5.64%54.11M
34.72%54.85M
Selling and administrative expenses
-13.63%23.45M
50.97%106.35M
29.91%27.42M
33.17%24.52M
65.49%27.26M
87.86%27.15M
87.19%70.45M
27.39%21.11M
134.46%18.41M
158.43%16.48M
-Selling and marketing expense
----
----
----
----
----
----
----
----
210.51%3.55M
650.96%3.52M
-General and administrative expense
-13.63%23.45M
50.97%106.35M
29.91%27.42M
33.17%24.52M
65.49%27.26M
87.86%27.15M
87.19%70.45M
12.28%21.11M
174.36%18.41M
178.95%16.48M
Research and development costs
-15.07%38.01M
-6.32%141.83M
10.60%38.59M
-13.25%30.97M
-28.30%27.52M
5.47%44.75M
-5.03%151.41M
-15.49%34.9M
-17.68%35.7M
11.76%38.38M
Operating profit
15.24%-58.42M
-28.02%-225.68M
-52.63%-65.98M
-120.55%-55.14M
32.22%-35.64M
-24.23%-68.93M
3.65%-176.29M
24.24%-43.23M
48.22%-25M
-34.81%-52.58M
Net non-operating interest income expense
-23.14%5.65M
63.45%27.59M
44.33%6.47M
51.09%6.71M
44.87%7.06M
138.44%7.35M
49.61%16.88M
-48.16%4.49M
149.05%4.44M
330.97%4.87M
Non-operating interest income
-23.14%5.65M
63.45%27.59M
44.33%6.47M
51.09%6.71M
44.87%7.06M
138.44%7.35M
49.61%16.88M
68.10%4.49M
45.24%4.44M
5.57%4.87M
Non-operating interest expense
----
----
----
----
----
----
--0
----
----
----
Total other finance cost
----
----
----
----
----
----
----
----
-10.98%1.14M
-66.21%1.18M
Other net income (expense)
-80.36%4.33M
93.03%-5.73M
71.15%-15.42M
-702.63%-23.58M
28.95%11.22M
153.29%22.05M
-1,472.73%-82.19M
-4,931.36%-53.43M
717.03%3.91M
2,161.14%8.7M
Gain on sale of security
-76.02%4.33M
78.49%-9.72M
43.82%-15.42M
-352.78%-23.57M
100.21%11.22M
155.27%18.06M
-810.91%-45.18M
-3,347.61%-27.44M
1,570.98%9.33M
1,427.49%5.6M
Special income (charges)
--0
110.79%3.99M
100.00%1K
99.98%-1K
--0
145.87%3.99M
-13,813.53%-37.01M
---25.99M
---5.41M
--3.1M
-Less：Restructuring and merger&acquisition
--0
-110.79%-3.99M
--0
--0
--0
-145.87%-3.99M
13,813.53%37.01M
--25.99M
--5.41M
---3.1M
-Gain on sale of property,plant,equipment
----
----
----
---1K
----
----
----
----
--0
----
Income before tax
-22.55%-48.44M
15.64%-203.82M
18.72%-74.92M
-332.51%-72.01M
55.48%-17.36M
57.85%-39.53M
-36.57%-241.6M
-86.34%-92.18M
64.68%-16.65M
-1.87%-39.01M
Income tax
0
0
0
0
0
0
-103.70%-1K
0
-1K
0
Net income
-22.55%-48.44M
15.64%-203.82M
18.72%-74.92M
-332.54%-72.01M
55.48%-17.36M
57.85%-39.53M
-36.54%-241.6M
-86.23%-92.18M
64.68%-16.65M
-1.87%-39.01M
Net income continuous Operations
-22.55%-48.44M
15.64%-203.82M
18.72%-74.92M
-332.54%-72.01M
55.48%-17.36M
57.85%-39.53M
-36.54%-241.6M
-86.23%-92.18M
64.68%-16.65M
-1.87%-39.01M
Minority interest income
Net income attributable to the parent company
-22.55%-48.44M
15.64%-203.82M
18.72%-74.92M
-332.54%-72.01M
55.48%-17.36M
57.85%-39.53M
-36.54%-241.6M
-86.23%-92.18M
64.68%-16.65M
-1.87%-39.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-22.55%-48.44M
15.64%-203.82M
18.72%-74.92M
-332.54%-72.01M
55.48%-17.36M
57.85%-39.53M
-36.54%-241.6M
-86.23%-92.18M
64.68%-16.65M
-1.87%-39.01M
Basic earnings per share
-17.65%-0.4
32.81%-1.72
33.68%-0.63
-238.89%-0.61
63.41%-0.15
67.92%-0.34
-19.07%-2.56
-58.33%-0.95
68.42%-0.18
12.77%-0.41
Diluted earnings per share
-17.65%-0.4
32.81%-1.72
33.68%-0.63
-238.89%-0.61
63.41%-0.15
67.92%-0.34
-19.07%-2.56
-58.33%-0.95
68.42%-0.18
12.77%-0.41
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 2.08%3.04M-50.61%22.5M-99.75%32K-98.80%348K740.06%19.15M112.56%2.98M223.37%45.56M1,490.54%12.77M889.83%29.11M32.73%2.28M
Operating revenue 2.08%3.04M-50.61%22.5M-99.75%32K-98.80%348K740.06%19.15M112.56%2.98M223.37%45.56M1,490.54%12.77M889.83%29.11M32.73%2.28M
Cost of revenue
Gross profit
Operating expense -14.52%61.46M11.87%248.19M17.88%66.01M2.54%55.49M-0.13%54.78M26.41%71.9M12.58%221.85M-3.21%56M5.64%54.11M34.72%54.85M
Selling and administrative expenses -13.63%23.45M50.97%106.35M29.91%27.42M33.17%24.52M65.49%27.26M87.86%27.15M87.19%70.45M27.39%21.11M134.46%18.41M158.43%16.48M
-Selling and marketing expense --------------------------------210.51%3.55M650.96%3.52M
-General and administrative expense -13.63%23.45M50.97%106.35M29.91%27.42M33.17%24.52M65.49%27.26M87.86%27.15M87.19%70.45M12.28%21.11M174.36%18.41M178.95%16.48M
Research and development costs -15.07%38.01M-6.32%141.83M10.60%38.59M-13.25%30.97M-28.30%27.52M5.47%44.75M-5.03%151.41M-15.49%34.9M-17.68%35.7M11.76%38.38M
Operating profit 15.24%-58.42M-28.02%-225.68M-52.63%-65.98M-120.55%-55.14M32.22%-35.64M-24.23%-68.93M3.65%-176.29M24.24%-43.23M48.22%-25M-34.81%-52.58M
Net non-operating interest income expense -23.14%5.65M63.45%27.59M44.33%6.47M51.09%6.71M44.87%7.06M138.44%7.35M49.61%16.88M-48.16%4.49M149.05%4.44M330.97%4.87M
Non-operating interest income -23.14%5.65M63.45%27.59M44.33%6.47M51.09%6.71M44.87%7.06M138.44%7.35M49.61%16.88M68.10%4.49M45.24%4.44M5.57%4.87M
Non-operating interest expense --------------------------0------------
Total other finance cost ---------------------------------10.98%1.14M-66.21%1.18M
Other net income (expense) -80.36%4.33M93.03%-5.73M71.15%-15.42M-702.63%-23.58M28.95%11.22M153.29%22.05M-1,472.73%-82.19M-4,931.36%-53.43M717.03%3.91M2,161.14%8.7M
Gain on sale of security -76.02%4.33M78.49%-9.72M43.82%-15.42M-352.78%-23.57M100.21%11.22M155.27%18.06M-810.91%-45.18M-3,347.61%-27.44M1,570.98%9.33M1,427.49%5.6M
Special income (charges) --0110.79%3.99M100.00%1K99.98%-1K--0145.87%3.99M-13,813.53%-37.01M---25.99M---5.41M--3.1M
-Less：Restructuring and merger&acquisition --0-110.79%-3.99M--0--0--0-145.87%-3.99M13,813.53%37.01M--25.99M--5.41M---3.1M
-Gain on sale of property,plant,equipment ---------------1K------------------0----
Income before tax -22.55%-48.44M15.64%-203.82M18.72%-74.92M-332.51%-72.01M55.48%-17.36M57.85%-39.53M-36.57%-241.6M-86.34%-92.18M64.68%-16.65M-1.87%-39.01M
Income tax 000000-103.70%-1K0-1K0
Net income -22.55%-48.44M15.64%-203.82M18.72%-74.92M-332.54%-72.01M55.48%-17.36M57.85%-39.53M-36.54%-241.6M-86.23%-92.18M64.68%-16.65M-1.87%-39.01M
Net income continuous Operations -22.55%-48.44M15.64%-203.82M18.72%-74.92M-332.54%-72.01M55.48%-17.36M57.85%-39.53M-36.54%-241.6M-86.23%-92.18M64.68%-16.65M-1.87%-39.01M
Minority interest income
Net income attributable to the parent company -22.55%-48.44M15.64%-203.82M18.72%-74.92M-332.54%-72.01M55.48%-17.36M57.85%-39.53M-36.54%-241.6M-86.23%-92.18M64.68%-16.65M-1.87%-39.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -22.55%-48.44M15.64%-203.82M18.72%-74.92M-332.54%-72.01M55.48%-17.36M57.85%-39.53M-36.54%-241.6M-86.23%-92.18M64.68%-16.65M-1.87%-39.01M
Basic earnings per share -17.65%-0.432.81%-1.7233.68%-0.63-238.89%-0.6163.41%-0.1567.92%-0.34-19.07%-2.56-58.33%-0.9568.42%-0.1812.77%-0.41
Diluted earnings per share -17.65%-0.432.81%-1.7233.68%-0.63-238.89%-0.6163.41%-0.1567.92%-0.34-19.07%-2.56-58.33%-0.9568.42%-0.1812.77%-0.41
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -